MARKETS
Markets

Integra LifeSciences' $2.1B Refinancing Merits A Closer Look

Oct 22, 2026 · 06:28 AM ET· updated 50m ago
Integra LifeSciences' $2.1B Refinancing Merits A Closer Look

Integra LifeSciences Holdings Corporation (NASDAQ:IART) completed a $2.1 billion refinancing on October 19, 2026. Its revolving credit commitment fell $700 million, from $1.3 billion to $600 million, while the new bank

Share
Why It Matters

Integra LifeSciences borrowed $2.1 billion to pay back older loans. Watch if the company keeps enough money to run smoothly.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.